Medical News: FDA Strengthens Warning on Transplant Drug - in Product Alert, Prescriptions from MedPage Today

Links shared publicly online about this topic.

  • 1,822
    total visits

Medical News: FDA Strengthens Warning on Transplant Drug - in Product Alert, Prescriptions from MedPage Today

medpagetoday.com

WASHINGTON -- A warning of a risk of pure red cell aplasia (PRCA) has been added to the label and prescribing information for mycophenolate mofetil (CellCept).

View full resource at medpagetoday.com

Tags: Organ Transplant Rejection Medication, Drug, FDA, CellCept, Transplantation

  • Share

Most Recently Shared on August 15, 2009 at 3:33 am By:

MedicalNews Medical News

FDA Strengthens Warning on Transplant Drug http://ow.ly/15L6sz

3 years ago...

Medical News: FDA Expands Black Box Warning on Iron Deficiency Drug - in Product Alert, Prescriptions from MedPage Today

medpagetoday.com — “WASHINGTON -- The FDA has strengthened the black box warning for injectable iron dextran (Dexferrum), cautioning physicians to try a test dose first, due to a risk of anaphalactic reactions and even dView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on October 17, 2009 at 12:43 am By:

medpagetoday MedPage Today Health News

Stronger black box warning issued for IV iron (dextran). Can cause severe anaphylaxis and even death. More: http://bit.ly/415Jhq

3 years ago...

Medical News: FDA Warns of New Risk on Transplant Drug - in Product Alert, Prescriptions from MedPage Today

medpagetoday.com — “WASHINGTON -- The FDA updated the prescribing information of the anti-rejection drug mycophenolic acid (myfortic) to reflect a danger of pure red cell aplasia (PCRA).View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on September 4, 2009 at 6:52 pm By:

Advertisement